| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| ATAI Life Sciences N.V. | 10%+ Owner | $41.8M | Sep 26, 2024 | ||
| George Jay Goldsmith | 10%+ Owner | $38.2M | Oct 24, 2024 | ||
| Ekaterina Malievskaia | 10%+ Owner | $38.2M | Oct 24, 2024 | ||
| Kabir Nath | Chief Executive Officer, Director | $960K | Aug 1, 2025 | ||
| Matthew Owens | General Counsel & CLO | $472K | Feb 1, 2024 | ||
| Teri Loxam | Chief Financial Officer | $306K | Mar 11, 2025 | ||
| Michael Falvey | Chief Financial Officer | $188K | Feb 2, 2023 | ||
| Annalisa Jenkins | Director | $134K | Jun 12, 2025 | ||
| Mary-Rose Hughes | Interim CFO | $10.3K | Feb 1, 2024 | ||
| Guy Goodwin | Chief Medical Officer | Mar 11, 2025 | |||
| Linda McGoldrick | Director | Jun 12, 2025 | |||
| Robert McQuade | Director | Jun 12, 2025 | |||
| Wayne J. Riley | Director | Jun 12, 2025 | |||
| David Norton | Director | Jun 12, 2025 | |||
| Jason Camm | Director | Jan 1, 2022 | |||
| Daphne Karydas | Director | Jun 12, 2025 | |||
| Justin D. Gover | Director | Jul 29, 2025 | |||
| Gino Santini | Director | Jun 12, 2025 | |||
| Thomas Lonngren | Director | Jun 12, 2025 | |||
| Jeffrey M. Jonas | Director | Oct 29, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|